Abstract
Sulfadoxine, a long-acting sulfonamide, and tetracycline were compared as regards their effectiveness in reducing transmission of cholera infection among the contacts of cholera patients in Calcutta. A total of 109 healthy family contacts of confirmed hospitalized cholera patients were treated with a single oral dose of sulfadoxine graded according to age. Another similar group of 101 contacts received 6 divided doses of oral tetracycline over a period of 3 days. All these contacts were bacteriologically examined for 15 days. Results showed that tetracycline was effective in significantly reducing the load of cholera infection from the 2nd to 6th day, while sulfadoxine was effective from the 3rd to the 6th day. The advantages and disadvantages of the two drugs as chemoprophylactic agents in cholera are discussed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergoend H., Löffler A., Amar R., Maleville J. Réactions cutanées survenues au cours de la prophylaxie de masse de la méningite cérébro-sinale par un sulfamide long-retard (a propos de 997 cas) Ann Dermatol Syphiligr (Paris) 1968;95(5):481–490. [PubMed] [Google Scholar]
- Gangarosa E. J., Saghari H., Emile J., Sanati A., Siadat H., Watanabe Y. Search for a mass chemotherapeutic drug for cholera control. A study of Vibrio excretion following single and multiple dose treatment. Bull World Health Organ. 1966;35(5):669–674. [PMC free article] [PubMed] [Google Scholar]
- McCormack W. M., Chowdhury A. M., Jahangir N., Ahmed A. B., Mosley W. H. Tetracycline prophylaxis in families of cholera patients. Bull World Health Organ. 1968;38(5):787–792. [PMC free article] [PubMed] [Google Scholar]